Abnormal Peyer's patch development and B cell gut homing drive IgA deficiency in Kabuki syndrome.
Kabuki syndrome (KS) is commonly caused by mutations in the histone modifying enzyme KMT2D. Immune dysfunction is frequently observed in individuals with KS, but the role of KMT2D in immune system function has not been identified. We sought to understand mechanisms driving Kabuki syndrome associated immune deficiency (hypogammaglobulinemia [low IgA], splenomegaly, and diminished immunization responses). We performed a comprehensive evaluation of humoral immunity and secondary lymphoid tissues in an established KS (Kmt2d+/βGeo) mouse model and validated select findings in a patient with Kabuki syndrome. Compared to wildtype littermates, Kmt2d+/βGeo mice demonstrated deficiencies in multiple B cell lineages and reduced serum IgA and elevated IgM levels across multiple ages. Kmt2d+/βGeo bone marrow, spleen, and intestine contained diminished numbers of IgA-secreting cells, while elevated germinal center B cells were found in mesenteric lymph node and Peyer's patches. Kmt2d+/βGeo mice have decreased size and numbers of Peyer's patches, a finding confirmed in human samples. We identified deficiency of Itgb7 RNA and protein expression, a gene encoding an adhesion protein that mediates intestinal homing, and we demonstrated KMT2D-dependent control of ITGB7 expression in a human cell line. Kmt2d haploinsufficiency has broad deleterious effects on B cell differentiation, specifically hampering gut lymphocyte homing and IgA+ plasma cell differentiation. Intestinal lymphoid defects caused by ITGB7 deficiency have not previously been recognized in KS and these results provide new mechanistic insights into the pathogenesis of Kabuki associated immune deficiency.